Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Jellinger

Showing results (341-350 of 364) with videos related to

Pageof 37
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1996
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological studyI Litvan, C A Mangone, A McKee, et al.
Brain : a Journal of Neurology|January 1, 1997
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological studyI Litvan, G Campbell, C A Mangone, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolismW Wesemann, M Solbach, R Nafe, et al.
Neurology|November 1, 1994
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)J J Hauw, S E Daniel, D Dickson, et al.
Journal of Neurology|October 20, 1999
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degenerationI Litvan, D A Grimes, A E Lang, et al.
Brain Research|January 16, 1989
Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's diseaseC Bancher, C Brunner, H Lassmann, et al.
Journal of Neural Transmission. General Section|January 1, 1995
Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I)P Riederer, W Gsell, L Calza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 3, 2004
(r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementiaL Frölich, M E Götz, M Weinmüller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseasesP Seeman, N H Bzowej, H C Guan, et al.
Brain Pathology (Zurich, Switzerland)|October 1, 1995
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)H Budka, A Aguzzi, P Brown, et al.
Pageof 37

Showing results (341-350 of 364) with videos related to

Sort By:
Pageof 37
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1996
Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological studyI Litvan, C A Mangone, A McKee, et al.
Brain : a Journal of Neurology|January 1, 1997
Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological studyI Litvan, G Campbell, C A Mangone, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Effect of lazaroid U-74389G on iron-induced reduction of striatal dopamine metabolismW Wesemann, M Solbach, R Nafe, et al.
Neurology|November 1, 1994
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy)J J Hauw, S E Daniel, D Dickson, et al.
Journal of Neurology|October 20, 1999
Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degenerationI Litvan, D A Grimes, A E Lang, et al.
Brain Research|January 16, 1989
Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's diseaseC Bancher, C Brunner, H Lassmann, et al.
Journal of Neural Transmission. General Section|January 1, 1995
Consensus on minimal criteria of clinical and neuropathological diagnosis of schizophrenia and affective disorders for post mortem research. Report from the European Dementia and Schizophrenia Network (BIOMED I)P Riederer, W Gsell, L Calza, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|March 3, 2004
(r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementiaL Frölich, M E Götz, M Weinmüller, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 1987
Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseasesP Seeman, N H Bzowej, H C Guan, et al.
Brain Pathology (Zurich, Switzerland)|October 1, 1995
Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases)H Budka, A Aguzzi, P Brown, et al.
Pageof 37